Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP

British Journal of Haematology

Volumn 144, Issue 2, 2009, Pages 245-250

  Roelofs, Anke J ^a   Jauhiainen, Marjo ^b   Mönkkönen, Hannu ^b   Rogers, Michael J ^a   Mönkkönen, Jukka ^b   Thompson, Keith ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alkylamines; Bisphosphonates; Gamma delta T cells; Isopentenyl diphosphate; Monocytes

Indexed keywords

BUTYLAMINE; COMPACTIN; DIMETHYLALLYL DIPHOSPHATE; ISOPENTENYL DIPHOSPHATE; PYROPHOSPHATE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL CULTURE; CONTROLLED STUDY; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CELL COMMUNICATION; CELLS, CULTURED; DIPHOSPHONATES; HEMITERPENES; HUMANS; IMIDAZOLES; LYMPHOCYTE ACTIVATION; MONOCYTES; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 58149086028     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07435.x     Document Type: Article

References (12)

1. Bonneville, M. Scotet, E. (2006) Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors. Current Opinion in Immunology, 18, 539 546.
2. Chen, T., Berenson, J., Vescio, R., Swift, R., Gilchick, A., Goodin, S., LoRusso, P., Ma, P., Ravera, C., Deckert, F., Schran, H., Seaman, J. Skerjanec, A. (2002) Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. Journal of Clinical Pharmacology, 42, 1228 1236.
3. Gober, H.J., Kistowska, M., Angman, L., Jeno, P., Mori, L. De Libero, G. (2003) Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. Journal of Experimental Medicine, 197, 163 168.
4. Hewitt, R.E., Lissina, A., Green, A.E., Slay, E.S., Price, D.A. Sewell, A.K. (2005) The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood γδ T cells in response to aminobisphosphonates is inhibited by statins. Clinical and Experimental Immunology, 139, 101 111.
5. Kunzmann, V., Bauer, E., Feurle, J., Weissinger, F., Tony, H.P. Wilhelm, M. (2000) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood, 96, 384 392.
6. Legay, F., Gauron, S., Deckert, F., Gosset, G., Pfaar, U., Ravera, C., Wiegand, H. Schran, H. (2002) Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine. Journal of Pharmaceutical and Biomedical Analysis, 30, 897 911.
7. Miyagawa, F., Tanaka, Y., Yamashita, S. Minato, N. (2001) Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. Journal of Immunology, 166, 5508 5514.
8. Mönkkönen, H., Auriola, S., Lehenkari, P., Kellinsalmi, M., Hassinen, I.E., Vepsäläinen, J. Mönkkönen, J.A. (2006) A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. British Journal of Pharmacology, 147, 437 445.
9. Tanaka, Y., Morita, C.T., Tanaka, Y., Nieves, E., Brenner, M.B. Bloom, B.R. (1995) Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature, 375, 155 158.
10. Thompson, K. Rogers, M.J. (2004) Statins prevent bisphosphonate-induced gamma delta-T-cell proliferation and activation in vitro. Journal of Bone and Mineral Research, 19, 278 288.
11. Thompson, K., Rojas-Navea, J. Rogers, M.J. (2006a) Alkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood, 107, 651 654.
12. Thompson, K., Rogers, M.J., Coxon, F.P. Crockett, J.C. (2006b) Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Molecular Pharmacology, 69, 1624 1632.